⌘K

Login Start Free

Home/Filings/4/0001144204-17-009645

4//SEC Filing

Sevion Therapeutics, Inc. 4

Accession 0001144204-17-009645

CIK 0001035354operating

View on SEC.gov Company Profile

Filed

Feb 15, 7:00 PM ET

Accepted

Feb 16, 6:30 PM ET

Size

5.6 KB

Accession

0001144204-17-009645

Insider Transaction Report

Form 4

Period: 2017-02-14

Sevion Therapeutics, Inc.SVON

Director

Transactions

Award
Company Stock Option
2017-02-14$0.11/sh+167,045$18,375→ 167,045 total
Exercise: $0.22From: 2017-02-14Exp: 2027-02-14→ Common Stock (167,045 underlying)

Footnotes (1)

[F1]Such options were granted to Mr. Braca in lieu of cash compensation under the Company's independent director compensation plan and are immediately exercisable.

Documents

1 file

4
v459866_form4.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Sevion Therapeutics, Inc.

CIK 0001035354

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001035354

Filing Metadata

Form type: 4
Filed: Feb 15, 7:00 PM ET
Accepted: Feb 16, 6:30 PM ET
Size: 5.6 KB

View on SEC.gov